"At Mosaic Life Care, we are committed to providing the best and safest care, while creating a warm, inviting environment for our patients, family members and caregivers. Our innovative life-care model combines traditional health care and a focus on key life elements that affect overall wellness. It is our commitment to the health, well-being and vitality of the communities and organizations we serve through health-related initiatives and opportunities."

During the past decade, Mosaic Life Care conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mosaic Life Care" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Mosaic Life Care" with 2 trials sponsored, "University of Nebraska" with 2 trials sponsored, "Aadi Bioscience, Inc." with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mosaic Life Care" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "Missouri Western State University" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Mosaic Life Care" are "Breast Cancer" (3 trials), "Endometrial Cancer" (2 trials), "Esophageal Cancer" (2 trials), "Melanoma" (2 trials) and "Metastatic Breast Cancer" (2 trials). Many other conditions were trialed in "Mosaic Life Care" in a lesser frequency.

Most popular intervention types in "Mosaic Life Care" are "Drug" (7 trials), "Other" (3 trials), "Device" (2 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Niraparib" (2 trials), "Abiraterone acetate (AA)" (1 trials), "Ablation" (1 trials), "Binimetinib" (1 trials) and "Crizotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mosaic Life Care" are 12 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Mosaic Life Care". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Mosaic Life Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mosaic Life Care, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Mosaic Life Care has several departments that took part in Clinical trials: "Saint Joseph Oncology Inc" - 79 trials